FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Volume 344:319-326 February 1, 2001 Number 5 Next

	Full Text PDF Editorial by Gellin, B. G. Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background There has been some concern that vaccination may precipitate the onset of multiple sclerosis or lead to relapses. Since the recent hepatitis B vaccination program in France, there have been new reports of an increased risk of active multiple sclerosis after vaccination.

Methods We conducted a case–crossover study to assess whether vaccinations increase the risk of relapse in multiple sclerosis. The subjects were patients included in the European Database for Multiple Sclerosis who had a relapse between 1993 and 1997. The index relapse was the first relapse confirmed by a visit to a neurologist and preceded by a relapse-free period of at least 12 months. Information on vaccinations was obtained in a standardized telephone interview and confirmed by means of medical records. Exposure to vaccination in the two-month risk period immediately preceding the relapse was compared with that in the four previous two-month control periods for the calculation of relative risks, which were estimated with the use of conditional logistic regression.

Results Of 643 patients with relapses of multiple sclerosis, 15 percent reported having been vaccinated during the preceding 12 months. The reports of 94 percent of these vaccinations were confirmed. Of all the patients, 2.3 percent had been vaccinated during the preceding two-month risk period as compared with 2.8 to 4.0 percent who were vaccinated during one or more of the four control periods. The relative risk of relapse associated with exposure to any vaccination during the previous two months was 0.71 (95 percent confidence interval, 0.40 to 1.26). There was no increase in the specific risk of relapse associated with tetanus, hepatitis B, or influenza vaccination (range of relative risks, 0.22 to 1.08). Analyses based on risk periods of one and three months yielded similar results.

Conclusions Vaccination does not appear to increase the short-term risk of relapse in multiple sclerosis.

Source Information

From the European Database for Multiple Sclerosis Coordinating Center and the Service de Neurologie A, Hôpital Neurologique, Lyons, France (C.C., V.B., S.V.); the Division of Clinical Epidemiology, Royal Victoria Hospital, and the Department of Epidemiology and Biostatistics, the Department of Medicine, and the McGill Pharmacoepidemiology Research Unit, McGill University, Montreal (S.S.); and the Department of Epidemiology, Aventis Pasteur, Lyons, France (P.S.).

Address reprint requests to Dr. Confavreux at the EDMUS Coordinating Center, Hôpital Neurologique, 59 blvd. Pinel, 69394 Lyons CEDEX 03, France.

Full Text of this Article

This article has been cited by other articles:

• Stassen, P. M., Kallenberg, C. G. M., Stegeman, C. A. (2009). Reply. Nephrol Dial Transplant 24: 3259-3259 [Full Text]  
• Ness, J. M., Bale, J. F. Jr (2009). Hepatitis vaccines and pediatric multiple sclerosis: Does timing or type matter?. Neurology 72: 870-871 [Full Text]  
• 'Chris' Delaney, J. A, Suissa, S. (2009). The case-crossover study design in pharmacoepidemiology. Stat Methods Med Res 18: 53-65 [Abstract]  
• Djeriri, K., Laurichesse, H., Merle, J. L., Charof, R., Abouyoub, A., Fontana, L., Benchemsi, N., Elharti, E., El Aouad, R., Chamoux, A., Beytout, J. (2008). Hepatitis B in Moroccan health care workers. Occup Med (Lond) 58: 419-424 [Abstract] [Full Text]  
• Stassen, P. M., Sanders, J.-S. F., Kallenberg, C. G. M., Stegeman, C. A. (2008). Influenza vaccination does not result in an increase in relapses in patients with ANCA-associated vasculitis. Nephrol Dial Transplant 23: 654-658 [Abstract] [Full Text]  
• Mikaeloff, Y., Caridade, G., Assi, S., Tardieu, M., Suissa, S., on behalf of the KIDSEP study group of the French, (2007). Hepatitis B vaccine and risk of relapse after a first childhood episode of CNS inflammatory demyelination. Brain 130: 1105-1110 [Abstract] [Full Text]  
• Hernan, M. A., Alonso, A., Hernandez-Diaz, S. (2006). Tetanus vaccination and risk of multiple sclerosis: a systematic review.. Neurology 67: 212-215 [Abstract] [Full Text]  
• Minden, S L, Frankel, D, Hadden, L, Perloff, J, Srinath, K P, Hoaglin, D C (2006). The Sonya Slifka Longitudinal Multiple Sclerosis Study: methods and sample characteristics. Mult Scler 12: 24-38 [Abstract]  
• Schwid, S. R., Decker, M. D., Lopez-Bresnahan, M., for the Rebif-Influenza Vaccine Study Investigator, (2005). Immune response to influenza vaccine is maintained in patients with multiple sclerosis receiving interferon beta-1a. Neurology 65: 1964-1966 [Abstract] [Full Text]  
• Leary, S M, Porter, B, Thompson, A J (2005). Multiple sclerosis: diagnosis and the management of acute relapses. Postgrad. Med. J. 81: 302-308 [Abstract] [Full Text]  
• Poland, G. A., Jacobson, R. M. (2004). Prevention of Hepatitis B with the Hepatitis B Vaccine. NEJM 351: 2832-2838 [Full Text]  
• Naismith, R. T., Cross, A. H. (2004). Does the hepatitis B vaccine cause multiple sclerosis?. Neurology 63: 772-773 [Full Text]  
• Karayiannis, P., Main, J., Thomas, H. C. (2004). Hepatitis vaccines. Br Med Bull 70: 29-49 [Full Text]  
• DeStefano, F., Verstraeten, T., Jackson, L. A., Okoro, C. A., Benson, P., Black, S. B., Shinefield, H. R., Mullooly, J. P., Likosky, W., Chen, R. T. (2003). Vaccinations and Risk of Central Nervous System Demyelinating Diseases in Adults. Arch Neurol 60: 504-509 [Abstract] [Full Text]  
• Offit, P. A., Hackett, C. J. (2003). Addressing Parents' Concerns: Do Vaccines Cause Allergic or Autoimmune Diseases?. Pediatrics 111: 653-659 [Abstract] [Full Text]  
• Etienney, I, Beaugerie, L, Viboud, C, Flahault, A (2003). Non-steroidal anti-inflammatory drugs as a risk factor for acute diarrhoea: a case crossover study. Gut 52: 260-263 [Abstract] [Full Text]  
• Ki, M., Park, T., Yi, S. G., Oh, J. K., Choi, B. (2003). Risk Analysis of Aseptic Meningitis after Measles-Mumps-Rubella Vaccination in Korean Children by Using a Case-Crossover Design. Am J Epidemiol 157: 158-165 [Abstract] [Full Text]  
• Rutschmann, O. T., McCrory, D. C., Matchar, D. B. (2002). Immunization and MS: A summary of published evidence and recommendations. Neurology 59: 1837-1843 [Abstract] [Full Text]  
• Lorber, B. (2002). Update in Infectious Diseases. ANN INTERN MED 137: 974-980 [Full Text]  
• Havinga, W., Offit, P. A., Gerber, M. A., Hackett, C., Marcuse, E., Gellin, B. (2002). Too Many Vaccinations?. Pediatrics 110: 648-649 [Full Text]  
• Belloni, C., Avanzini, M. A., De Silvestri, A., Martinetti, M., Pasi, A., Coslovich, E., Autelli, M., Masanti, M. L., Cuccia, M., Tinelli, C., Rondini, G., Lorini, R. (2002). No Evidence of Autoimmunity in 6-Year-Old Children Immunized at Birth With Recombinant Hepatitis B Vaccine. Pediatrics 110: e4-4 [Abstract] [Full Text]  
• Sibilia, J, Maillefert, J F (2002). Vaccination and rheumatoid arthritis. Ann Rheum Dis 61: 575-576 [Full Text]  
• Confavreux, C. (2002). Infections and the risk of relapse in multiple sclerosis. Brain 125: 933-934 [Full Text]  
• Buljevac, D., Flach, H. Z., Hop, W. C. J., Hijdra, D., Laman, J. D., Savelkoul, H. F. J., van der Meche, F. G. A., van Doorn, P. A., Hintzen, R. Q. (2002). Prospective study on the relationship between infections and multiple sclerosis exacerbations. Brain 125: 952-960 [Abstract] [Full Text]  
• Burt, R. K., Slavin, S., Burns, W. H., Marmont, A. M. (2002). Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: getting closer to a cure?. Blood 99: 768-784 [Abstract] [Full Text]  
• Ahmed, F., Singleton, J. A., Franks, A. L. (2001). Influenza Vaccination for Healthy Young Adults. NEJM 345: 1543-1547 [Full Text]  
• Dennehy, P. H. (2001). Active Immunization in the United States: Developments over the Past Decade. Clin. Microbiol. Rev. 14: 872-908 [Abstract] [Full Text]  
• Begaud, B., Alperovitch, A., Hanslik, T., Viboud, C., Flahault, A., Gout, O., Sturkenboom, M. C.J.M., Fourrier, A., Buttinelli, C., Salvetti, M., Ristori, G., Hostetler, L., Ascherio, A., Zhang, S. M., Walker, A. M., Confavreux, C., Suissa, S., Saddier, P. (2001). Vaccinations and Multiple Sclerosis. NEJM 344: 1793-1796 [Full Text]  
• Rathore, M. H. (2001). Guillain-Barre Syndrome Not Related to MMR. AAP Grand Rounds 5: 46-47 [Full Text]  
• (2001). No Significant Risk to Vaccination in MS. JWatch Neurology 2001: 1-1 [Full Text]  
• (2001). From Rumor to Reality: Vaccinations Not Associated with MS Onset or Relapse. JWatch Infect. Diseases 2001: 1-1 [Full Text]  
• (2001). No Link Between Vaccination and Multiple Sclerosis. JWatch General 2001: 1-1 [Full Text]  
• Gellin, B. G., Schaffner, W. (2001). The Risk of Vaccination -- The Importance of "Negative" Studies. NEJM 344: 372-373 [Full Text]  
• DeStefano, F., Verstraeten, T., Newman, J.P., Noseworthy, J. H., Poland, G. A. (2001). Multiple Sclerosis. NEJM 344: 381-382 [Full Text]